sign in · help · news · about ·

BibSonomy :: user :: kanefendt ::

tag user group author concept BibTeX key search:all search:kanefendt

The blue social bookmark and publication sharing system.

>
|
<

bookmarks

bookmarks per page: 5 10 20 50 100

RSS BibTeX RDF more

publications

(4)

<< < 1 > >>

Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor
Anat Norden-Zfoni, Jayesh Desai, Judith Manola, Paul Beaudry, Jeremy Force, Robert Maki, Judah Folkman, Carlo Bello, Charles Baum, Sam E. DePrimo, David R. Shalinsky, Goerge D. Demetri, and John V. Heymach Clin Cancer Res 13(9):2643-2650 (2007)
to Cells Endothelial Monocytes Population SU11248 Tyrosine cells identify by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Effect of treatment with sunitinib malate, a multitargeted tyrosine kinase inhibitor, on circulating plasma levels of VEGF, soluble VEGF receptors 2 and 3, and soluble KIT in patients with metastatic breast cancer
S. E. Deprimo, C. Friece, X. Huang, J. Smeraglia, L. Sherman, M. Collier, C. Baum, A. D. Elias, H. J. Burstein, and K. D. Miller J Clin Oncol Meeting Abstracts 24(18_suppl):578 (2006)
to Outcome Proteins Research SU11248 Treatment Tyrosine analysis methods protein response therapy by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Modulation of biomarkers of angiogenesis during treatment with SU11248 sunitinib malate in patients with advanced malignancies: Proceedings of the 97th Annual Meeting of the American Association for Cancer Research
Samuel E. DePrimo, Guy Toner, Paul Mitchell, Richard Boer, Peter Gibbs, Rodney Hicks, Grant McArthur, Nicoletta Brega, Timothy McCarthy, and Carlo Bello (Eds.). 47, Philadelphia, PA, AACR, (2006)
to Research SU11248 by kanefendt on Feb 5, 2010, 11:28 AM
BibTeX (0)
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia AML or not amenable to conventional therapy for the disease
W. Fiedler, H. Serve, H. Dohner, M. Schwittay, O. G. Ottmann, A. M. O'Farrell, C. L. Bello, R. Allred, W. C. Manning, J. M. Cherrington, S. G. Louie, W. Hong, N. M. Brega, G. Massimini, P. Scigalla, W. E. Berdel, and D. K. Hossfeld Blood 105(3):986-993 (2005)
to & 3 Acute Aged Clearance Endothelial Factor Female Follow-Up Genotype Growth Human Humans Hypertension Indoles Kinase Kinases Leukemia Lung Male Metabolic Middle Mutation Myeloid Pharmacokinetics Platelet-Derived Protein-Tyrosine Proteins Proto-Oncogene Pyrroles Rate Receptor Receptors Research SU11248 Studies Tyrosine Vascular analysis antagonists cells drug fms-Like genetics inhibitors protein response therapeutic therapy toxicity use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)

<< < 1 > >>publications per page: 5 10 20 50 100

a gripper